beta

ADMA

ADMA Biologics Inc

Adma

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.

Market Cap: 179 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.admabiologics.com

Shares Outstanding: 45.3 Million

Float: 45.2 Million

Dividend: 0.0 (0.0%)

Beta: 2.264817

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 146 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1241 trading days

From: 2014-11-06 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud